Finerenone for kidney disease without certain blood pressure drugs
Treatments studied
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests if finerenone can protect kidneys in people with chronic kidney disease who are not taking common blood pressure medications called ACE inhibitors, ARBs, or renin inhibitors. It may help slow kidney damage.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older with chronic kidney disease.
- Your kidney function (eGFR) must be between 25 and 120 mL/min/1.73 m².
- You must have elevated protein in your urine (UACR from 100 to less than 5000 mg/g).
- Your potassium level must be 5.0 mmol/L or lower at screening.
- You cannot be currently taking or have taken in the past 8 weeks any ACE inhibitor, ARB, or renin inhibitor (like aliskiren).
- You must not have type 1 diabetes or very high blood sugar (HbA1c over 11%).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the medication finerenone works in everyday medical practice for people with type 2 diabetes and certain stages of chronic kidney disease. It aims to see how safe and effective the treatment is outside of a clinical trial setting.
This trial tests if a medicine called finerenone can protect kidney function in people with type 2 diabetes and early-to-moderate chronic kidney disease. It may be an option if you are already on blood pressure medication and have some protein in your urine.
This observational study tracks how well finerenone (a kidney-protective medication) works in adults with type 2 diabetes and chronic kidney disease in Spain. Researchers will measure changes in kidney function and disease risk over time to better understand the medication's real-world benefits.
This trial studies how safely finerenone works over 18 months in children and young adults with chronic kidney disease who also take an ACE inhibitor or ARB. It aims to better understand long-term side effects when used together with standard kidney blood-pressure medicines.
This trial tests whether a drug called finerenone can help people recover from acute kidney injury (AKI), a sudden loss of kidney function. It might reduce further kidney damage and improve recovery.
This trial tests a medication called finerenone to see if it can lower the amount of protein in your urine, which is a sign of kidney damage. It is for people with type 2 diabetes and chronic kidney disease who are already on standard blood pressure medications.
Hear when a new Chronic kidney disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.